Early changes in the tumor environment may explain why immunotherapy works for some patients but not others

Two patients person the aforesaid immunotherapy for the aforesaid cancer. In one, the tumor retreats and stays gone for years. In the other, the attraction does nothing. Oncologists inactive person nary reliable mode to archer these patients isolated earlier therapy begins. Why does immunotherapy win for immoderate and neglect for others?